house · trading 2015-04-06 → 2019-05-02
*Notional-weighted price return on disclosed buys, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2019-05-02 | WAB | BUY | $1K–$15K | $74.98 | $269.53 2026-06-26 | +259.5% |
| 2019-04-26 | GSK | BUY | $1K–$15K | $40.40 | $52.50 2026-06-26 | +29.9% |
| 2016-09-06 | ABBV | SELL | $1K–$15K | $64.61 | $253.35 2026-06-26 | -292.1% exit |
| 2016-01-06 | ABBV | SELL | $1K–$15K | $57.38 | $253.35 2026-06-26 | -341.5% exit |
| 2015-04-06 | ABBV | SELL | $1K–$15K | $57.61 | $253.35 2026-06-26 | -339.8% exit |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Hon. Rohit Khanna | 3 · ABBV, GSK, WAB |
| Hon. Virginia Foxx | 2 · ABBV, GSK |
| Hon. Kenny Marchant | 2 · ABBV, GSK |
| Hon. Kurt Schrader | 2 · ABBV, GSK |
| Hon. Mike Kelly | 2 · ABBV, GSK |
| Hon. Fred Upton | 2 · ABBV, GSK |
| Hon. James B. Renacci | 2 · ABBV, GSK |
| Hon. John K. Delaney | 2 · GSK, WAB |
| Hon. Josh Gottheimer | 2 · ABBV, GSK |
| Hon. David P. Roe | 2 · ABBV, GSK |
| Hon. George Holding | 2 · ABBV, GSK |
| Hon. Katherine M. Clark | 2 · ABBV, GSK |